A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.

Background: Oxymetazoline and xylometazoline are locally effective and direct acting drugs that relieve nasal congestion. The aim of this study was to objectively determine and compare the decongestive effects of oxymetazoline and xylometazoline in healthy subjects. Methods: The study population com...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 67; no. 1; pp. 19 - 24
Autores principales: Eskiizmir G, Hirçin Z, Özyurt B, Ünlü H
Formato: research tables/charts Journal Article
Publicado: Springer Nature Jan2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104972094&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104972094
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Jan2011
      vid: 67
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104972094
        56792763
        10.1007/s00228-010-0941-z
        NLM21069518
        104972094
      ppf: 19
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.
      aug:
        au:
          Eskiizmir G
          Hirçin Z
          Özyurt B
          Ünlü H
        affil: Department of Otorhinolaryngology, Celal Bayar University, 45010 Manisa Turkey
      sug:
        subj:
          Oxymetazoline Pharmacodynamics
          Vasoconstrictor Agents, Nasal Pharmacodynamics
          Oxymetazoline Therapeutic Use
          Vasoconstrictor Agents, Nasal Therapeutic Use
          Airway Resistance Drug Effects
          Comparative Studies
          Human
          Rhinometry, Acoustic
          Kruskal-Wallis Test
          Mann-Whitney U Test
          Male
          Female
          Adult
          Manometry Methods
          Data Analysis Software
          Nasal Mucosa Drug Effects
          Nasal Obstruction Drug Therapy
          Oxymetazoline Administration and Dosage
          Vasoconstrictor Agents, Nasal Administration and Dosage
          Adult: 19-44 years
          Male
          Female
      ab: Background: Oxymetazoline and xylometazoline are locally effective and direct acting drugs that relieve nasal congestion. The aim of this study was to objectively determine and compare the decongestive effects of oxymetazoline and xylometazoline in healthy subjects. Methods: The study population comprised thirty healthy adults. All subjects underwent active anterior rhinomanometry (AARhm) and acoustic rhinometry (AR) tests following the application of oxymetazoline, xylometazoline, or placebo (physiological saline). The change in nasal resistance, nasal airflow, and different cross-sectional areas (CSAs) of the nasal cavity in the subjects were examined for each solution separately. The measurements were obtained over a 1-h period (baseline and 1, 15, 30, and 60 min post-dosing). All results were analyzed using the Kruskal-Wallis test and the Mann-Whitney U test. Results: A total of 6,300 measurements of AARhm and AR were obtained. The application of placebo did not cause a statistically significant change in nasal resistance, nasal airflow, and CSAs (CSA1, 2, and 3, respectively) of the nasal cavity. In contrast, statistically significant changes in nasal resistance (inspiration p = 0.000 and p = 0.004; expiration p = 0.000 and p = 0.000), nasal airflow (inspiration p = 0.000 and p = 0.004; expiration p = 0.000 and p = 0.000), and CSAs of the nasal cavity (CSA2 p = 0.000 and p = 0.000, CSA3 p = 0.000 and p = 0.00), with the exception of CSA1 ( p = 0.982 and p = 0.994), were obtained after the application of oxymetazoline and xylometazoline. A comparison of oxymetazoline and xylometazoline based on nasal resistance, nasal airflow, and CSAs of the nasal cavity demonstrated no statistically significant difference, except for CSA3. Conclusion: Oxymetazoline and xylometazoline are fast-acting and potent topical decongestants that have similar decongestive effects.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N